Suven Pharmaceuticals Limited Cash Flow Reinvestment Rate
Suven Pharmaceuticals Limited cash flow reinvestment rate. Suven Pharmaceuticals Limited (SUVENPHAR) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs255.04 Million. Explore Suven Pharmaceuticals Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Suven Pharmaceuticals Limited (2019–2025)
Cash flow reinvestment rate of Suven Pharmaceuticals Limited from 2019 to 2025. Historical reinvestment intensity for Suven Pharmaceuticals Limited across 7 annual periods. Explore Suven Pharmaceuticals Limited (SUVENPHAR) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Suven Pharmaceuticals Limited Cash Flow Reinvestment Rate by Year (2019–2025)
Suven Pharmaceuticals Limited cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Suven Pharmaceuticals Limited. For the full cash flow conversion analysis, see Suven Pharmaceuticals Limited (SUVENPHAR) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.43x | Rs4.11 Billion | Rs2.88 Billion | Rs1.56 Billion | ▲ +23.5% |
| 2024 | 1.15x | Rs4.14 Billion | Rs3.58 Billion | Rs517.87 Million | ▲ +8.4% |
| 2023 | 1.07x | Rs4.81 Billion | Rs4.51 Billion | Rs2.86 Billion | ▲ +168.0% |
| 2022 | 0.40x | Rs1.31 Billion | Rs3.30 Billion | Rs751.87 Million | ▼ -51.0% |
| 2021 | 0.81x | Rs3.11 Billion | Rs3.83 Billion | Rs1.11 Billion | ▼ -20.4% |
| 2020 | 1.02x | Rs4.25 Billion | Rs4.16 Billion | Rs994.15 Million | ▼ -29.9% |
| 2019 | 1.46x | Rs733.40 Million | Rs504.05 Million | Rs567.86 Million | — |